Wolfsbane can stop a human heart with an amount small enough to hide under a fingernail. Larkspur has killed livestock across the American West for as long as ranchers have kept records. Both plants have also been used medicinally across multiple cultures for thousands of years, treated as a source of pain relief and other treatments despite, or perhaps because of, their extraordinary toxicity. A study published in the journal Molecular Plant and reported publicly starting July 31, 2026, finally explains the biochemical machinery behind that dual identity, identifying the specific set of enzymes these plants use to construct one of their most pharmacologically interesting compounds.

Plants that kill and heal through the same chemistry

The research, a collaboration between Björn Hamberger's laboratory at Michigan State University and Tomáš Pluskal's group at the Czech Academy of Sciences, focused on a class of chemical compounds called diterpenoid alkaloids, complex molecules responsible for both wolfsbane and larkspur's neurotoxic effects and their documented therapeutic uses against pain, malaria, cancer, and agricultural pests. Wolfsbane, also known as monkshood or aconite, ranks among the most poisonous plants commonly found in ordinary gardens; its toxins can be absorbed through skin contact with damaged plant material, and ingesting even small amounts has caused fatal cardiac arrhythmias in documented medical cases.

Despite that danger, or in some traditions specifically because of the powerful biological activity it demonstrates, aconite preparations have circulated in various traditional medicine practices around the world, with associated poisonings well documented in medical literature. Larkspur carries similarly serious toxicity risks to both people and livestock. Understanding exactly how these plants construct their most bioactive compounds has remained a genuine scientific puzzle, largely because the plants themselves produce these particular molecules in extremely small quantities, making direct extraction and study difficult.

A collaboration that started at a conference

According to Hamberger, the joint research effort began somewhat by chance. His Michigan State lab and Pluskal's team at the Czech Academy of Sciences were independently pursuing the same class of compounds when the two researchers met at a scientific conference. "When this happens, we can either go our own ways, or come together, and it's joining up that always leads to the best science," Hamberger said, describing the decision to combine efforts rather than compete on parallel, separate tracks.

The combined team then conducted transcriptome sequencing, essentially cataloging which genes are actively switched on within plant tissue, across multiple species including Delphinium grandiflorum, a type of larkspur, along with Aconitum plicatum and Aconitum lycoctonum, both wolfsbane relatives. Researchers supplemented that direct sequencing work with publicly available genetic data from four additional Aconitum species already known to produce diterpenoid alkaloids, giving the comparative analysis a broader genetic base to work from than any single species alone could provide.

Searching through thousands of genes for the right six

Garret Miller, a Michigan State alum and co-first author of the study now working as an assistant professor of biotechnology at the University of Michigan-Flint, described the identification process as something close to a genetic scavenger hunt. The research team compared which genes activated in which plant tissues across the various larkspur and wolfsbane species studied, gradually narrowing an enormous initial pool of candidates down to a manageable set of promising genetic leads worth testing directly.

To confirm which genes actually mattered, researchers inserted the candidate genetic sequences into tobacco plants, using them as convenient living biofactories rather than attempting to work with the far more difficult and dangerous source plants directly. When the modified tobacco plants were chemically analyzed, the team found what they had been looking for: a complete assembly line consisting of six distinct enzymes, specifically a pair of terpene synthases, three cytochrome P450 enzymes, and a reductase, working in sequence to construct a diterpenoid alkaloid called atisinium.

An unexpected twist in the molecule's construction

Among the enzymes identified, the reductase stood out as scientifically unusual, described by researchers as bearing little resemblance to any previously characterized enzyme of its type. Beyond simply assembling atisinium's complex final structure, the six-enzyme pathway also facilitated the incorporation of an unexpected nitrogen source into the molecule, a detail the research team had not anticipated going into the study and one that adds a genuinely novel biochemical wrinkle to how this class of compounds gets built inside the plant.

That nitrogen-incorporation detail matters beyond simple scientific curiosity. Diterpenoid alkaloids' complex nitrogen-containing structure is part of what makes them so difficult to synthesize artificially in a laboratory setting using conventional chemistry, and difficult to extract in meaningful quantities directly from the source plants given how sparingly the plants naturally produce them. Identifying precisely how the plant itself solves that construction problem, nitrogen incorporation included, gives researchers a genuine biochemical blueprint to work from rather than having to reverse-engineer the process purely through trial-and-error laboratory chemistry.

Why a safety warning belongs in every version of this story

It is worth stating plainly, as several outlets covering this research have emphasized: nothing in this study suggests any home, garden, or supplement-based use of wolfsbane or larkspur. Both plants remain genuinely dangerous, should never be handled without gloves, and should never be consumed in any preparation under any circumstances. Aconite poisonings continue to appear in medical literature specifically because these plants circulate in some traditional medicine contexts despite carrying serious, well-documented, and sometimes fatal risk. Anyone who suspects an exposure to either plant should contact Poison Control immediately rather than waiting for symptoms to appear, since the cardiac effects associated with aconite toxicity in particular can develop rapidly.

What comes next: moving the biofactory to yeast

Having identified the initial six-enzyme biochemical pathway inside tobacco plants, researchers describe transferring the same genetic instructions into an engineered host organism such as yeast as the logical next step toward scalable production. Yeast-based biosynthesis has already proven successful for manufacturing other complex, naturally derived pharmaceutical compounds at commercial scale, offering a considerably more sustainable and controllable production method than attempting to extract vanishingly small natural quantities directly from toxic source plants growing in the wild.

Hamberger framed the team's broader ambition in terms of environmental sustainability alongside medical potential. "Our vision is to provide green, sustainable tools that will allow us harness these plants' natural power," he said, describing a production pathway that would let researchers study and eventually develop these compounds' medicinal properties without depending on wild plant harvesting or hazardous direct extraction from living aconite and larkspur specimens.

Why this matters beyond two specific poisonous flowers

Diterpenoid alkaloids represent a considerably larger chemical family than the single compound, atisinium, this study focused on directly. By establishing the first documented biochemical steps required to build even one member of that family, researchers have given themselves a genuine foothold for investigating related compounds across the broader diterpenoid alkaloid group, many of which likely share similar biosynthetic logic even if their specific enzyme requirements differ in detail.

For a class of plants humanity has cautiously relied on and feared in roughly equal measure across thousands of years of recorded use, finally mapping the precise genetic and enzymatic machinery behind their most medically interesting chemistry offers something neither traditional herbal knowledge nor modern toxicology reports alone could previously provide: a concrete, reproducible path toward harnessing these compounds' therapeutic potential without needing to handle the dangerous plants that originally produce them.

---

*Sources cited in this article include the peer-reviewed study published in Molecular Plant, and reporting from ScienceDaily, Phys.org, SciTechDaily, EurekAlert, News-Medical.net, and BioTechniques covering research led by Björn Hamberger of Michigan State University and Tomáš Pluskal of the Czech Academy of Sciences. All figures reflect reporting available as of August 3, 2026.*